BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31484075)

  • 21. N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.
    Tharmarajah K; Everest-Dass A; Vider J; Liu X; Freitas JR; Mostafavi H; Bettadapura J; von Itzstein M; West NP; Taylor A; Mahalingam S; Zaid A
    J Virol; 2022 Sep; 96(17):e0099922. PubMed ID: 36000846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
    Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
    Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.
    Hong JP; McCarthy MK; Davenport BJ; Morrison TE; Diamond MS
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis.
    Assunção-Miranda I; Cruz-Oliveira C; Da Poian AT
    Biomed Res Int; 2013; 2013():973516. PubMed ID: 24069610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of vector specificity of o'nyong nyong and chikungunya viruses in Anopheles and Aedes mosquitoes.
    Vanlandingham DL; Tsetsarkin K; Klingler KA; Hong C; McElroy KL; Lehane MJ; Higgs S
    Am J Trop Med Hyg; 2006 Apr; 74(4):663-9. PubMed ID: 16607002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models.
    Nguyen W; Nakayama E; Yan K; Tang B; Le TT; Liu L; Cooper TH; Hayball JD; Faddy HM; Warrilow D; Allcock RJN; Hobson-Peters J; Hall RA; Rawle DJ; Lutzky VP; Young P; Oliveira NM; Hartel G; Howley PM; Prow NA; Suhrbier A
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32380760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.
    Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG
    mSphere; 2018; 3(2):. PubMed ID: 29577083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FHL1 is a major host factor for chikungunya virus infection.
    Meertens L; Hafirassou ML; Couderc T; Bonnet-Madin L; Kril V; Kümmerer BM; Labeau A; Brugier A; Simon-Loriere E; Burlaud-Gaillard J; Doyen C; Pezzi L; Goupil T; Rafasse S; Vidalain PO; Bertrand-Legout A; Gueneau L; Juntas-Morales R; Ben Yaou R; Bonne G; de Lamballerie X; Benkirane M; Roingeard P; Delaugerre C; Lecuit M; Amara A
    Nature; 2019 Oct; 574(7777):259-263. PubMed ID: 31554973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes.
    Vanlandingham DL; Hong C; Klingler K; Tsetsarkin K; McElroy KL; Powers AM; Lehane MJ; Higgs S
    Am J Trop Med Hyg; 2005 May; 72(5):616-21. PubMed ID: 15891138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High rates of o'nyong nyong and Chikungunya virus transmission in coastal Kenya.
    LaBeaud AD; Banda T; Brichard J; Muchiri EM; Mungai PL; Mutuku FM; Borland E; Gildengorin G; Pfeil S; Teng CY; Long K; Heise M; Powers AM; Kitron U; King CH
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003436. PubMed ID: 25658762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O'nyong nyong virus molecular determinants of unique vector specificity reside in non-structural protein 3.
    Saxton-Shaw KD; Ledermann JP; Borland EM; Stovall JL; Mossel EC; Singh AJ; Wilusz J; Powers AM
    PLoS Negl Trop Dis; 2013; 7(1):e1931. PubMed ID: 23359824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquito.
    Cereghino C; Roesch F; Carrau L; Hardy A; Ribeiro-Filho HV; Henrion-Lacritick A; Koh C; Marano JM; Bates TA; Rai P; Chuong C; Akter S; Vallet T; Blanc H; Elliott TJ; Brown AM; Michalak P; LeRoith T; Bloom JD; Marques RE; Saleh MC; Vignuzzi M; Weger-Lucarelli J
    PLoS Pathog; 2023 Apr; 19(4):e1010491. PubMed ID: 37018377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development.
    Tuekprakhon A; Puiprom O; Sasaki T; Michiels J; Bartholomeeusen K; Nakayama EE; Meno MK; Phadungsombat J; Huits R; Ariën KK; Luplertlop N; Shioda T; Leaungwutiwong P
    PLoS One; 2018; 13(12):e0208851. PubMed ID: 30557365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging alphaviruses in the Americas: Chikungunya and Mayaro.
    Figueiredo ML; Figueiredo LT
    Rev Soc Bras Med Trop; 2014; 47(6):677-83. PubMed ID: 25626645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
    Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
    J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
    Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
    J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus.
    Kantor AM; Lin J; Wang A; Thompson DC; Franz AWE
    J Med Entomol; 2019 Apr; 56(3):832-843. PubMed ID: 30668762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.